PLoS ONE 2015-01-01

Characterization of Anti-Citrinin Specific ScFvs Selected from Non-Immunized Mouse Splenocytes by Eukaryotic Ribosome Display.

Haiwei Cheng, Yifei Chen, Yi Yang, Xueqiu Chen, Xiaolu Guo, Aifang Du

文献索引:PLoS ONE 10 , e0131482, (2015)

全文:HTML全文

摘要

Single chain variable fragments (scFvs) against citrinin (CIT) were selected from a scFv library constructed from the splenocytes of non-immunized mice by an improved eukaryotic ribosome display technology in this study. Bovine serum albumin (BSA)/ CIT-BSA and ovalbumin (OVA)/ CIT-OVA were used as the antigens to select specific anti-CIT scFvs. Eukaryotic in situ RT-PCR method was used to recover the selected mRNA after every affinity selection. After six rounds of ribosome display, expression vector pTIG-TRX carrying specific scFv DNAs were constructed and transformed into Escherichia coli BL21 (DE3) for protein expression. Thirteen positive clones were selected out of which three (designated 23, 68 and 109) showed high binding activity and specificity to CIT by indirect ELISA, while no clone showed binding activity with carrier proteins. The three scFvs showed high specificity to CIT and the cross reactivity with other mycotoxins was below 0.01% as determined by indirect competitive ELISA. These specific scFvs offer a potential novel immunoassay method for CIT residues. This study confirmed the effectiveness of the improved eukaryotic ribosome display system and could be used as a reference for the selection of scFvs specific to other small molecules using ribosome display.


相关化合物

  • 1-乙基-(3-二甲基氨...
  • 4-氯-1-萘酚
  • 1,2-二氯乙烷
  • 伏马毒素 B1
  • L-甲状腺素钠五水合...
  • 橘霉素
  • 黄曲霉素 B1
  • 吗啉乙磺酸

相关文献:

Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.

2015-02-01

[Biomaterials 42 , 42-51, (2014)]

Altering in vivo macrophage responses with modified polymer properties.

2015-07-01

[Biomaterials 56 , 187-97, (2015)]

Species-dependent binding of new synthesized bicalutamide analogues to albumin by optical biosensor analysis.

2015-01-01

[J. Pharm. Biomed. Anal. 111 , 324-32, (2015)]

Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery.

2015-06-20

[Int. J. Pharm. 487 , 81-90, (2015)]

Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy.

2014-10-01

[Biomed. Pharmacother. 68(8) , 979-87, (2014)]

更多文献...